名稱 | CYP2B6*6 Reference Standard |
型號 | CBPA0037 |
報價 | |
特點 | CYP2B6*6 Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準品
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準品
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準品
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準品
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準品
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準品
- IDH基因診斷標(biāo)準品
- 有關(guān)腫瘤細胞的基因突變研究講解
- 細胞因子風(fēng)暴和自身免疫性炎癥治療新靶點GM-CSF
- 【新品上線】一種安全高效的中和抗體體外篩選模型
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準品 > 用藥指導(dǎo) > CBPA0037CYP2B6*6 Reference Standard
- 詳細內(nèi)容
CBPA0037 | |
Format | Genomic DNA |
Description | CYP2B6 (Cytochrome P450 Family 2 Subfamily B Member 6) is a Protein Coding gene. Diseases associated with CYP2B6 include Efavirenz, Poor Metabolism Of and Acute Frontal Sinusitis. Among its related pathways are Vortioxetine Pathway, Pharmacokinetics and Oxidation by cytochrome P450. |
Technical Data | |
Gene | CYP2B6 |
Mutation Type 1 | AA Change: p.Q172H |
DNA Change: NM_000767.5:c.516G>T | |
Chr position (GRCh38): chr19:41006936G>T | |
Mutation Type 2 | AA Change: p.K262R |
DNA Change: NM_000767.5:c.785A>G | |
Chr position (GRCh38): chr19:41009358A>G | |
Allelic Frequency | 50% |
Zygosity | Heterozygous |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | Figure 1. CYP2B6*6 Reference Standard p.Q172H Figure 2. CYP2B6*6 Reference Standard p.K262R |
Storage | 4°C |
Expiry | 36 months from the date of manufacture |